RARE DISEASERESEARCH ATLAS

ORPHA:675628

TLR8-related inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome

low confidenceDisorder

Also known as: INFLTR8 · Toll-like receptor 8-associated inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome

Query health: suspect — Source fetch failed for trials.

Publications

13,820

Trials

Interventional, condition-specific

Researchers

116

Distinct authors in sample

Gene link

TLR8

Strong

Readiness

3/6

Stages with a signal

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (4)

IMD98 · X-linked immunodeficiency with autoinflammation · immunodeficiency 98 with autoinflammation, X-linked · inflammation, neutropenia, bone marrow failure, and lymphoproliferation caused by TLR8

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedPresent

    Strong — TLR8

  2. LiteraturePresent

    13,820 matched papers (9,458 in last 10 years) Source

  3. Phenotype characterisedPresent

    20 HPO annotations (e.g. Antineutrophil antibody positivity; Hemophagocytosis; Growth delay) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot checked

    Trial fetch failed or incomplete

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (TLR8).

GenCC classification: Strong.

Phenotypes (Monarch / HPO)

20

Associated phenotypes · MONDO:0024777

  • Antineutrophil antibody positivity
  • Hemophagocytosis
  • Growth delay
  • Thrombocytopenia
  • Splenomegaly

Showing 5 of 20 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

13,820

13,820 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

13,820 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

9,458 in the last 10 years · low confidence

Phrase hits: 14 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

116

Distinct author names in 14 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Cooper MA8 papers · 2026

    Division of Rheumatology/Immunology and.

    Papers in Europe PMC
  2. 02
    Aluri J4 papers · 2026

    Division of Rheumatology/Immunology and.

    Papers in Europe PMC
  3. 03
    Rao VK3 papers · 2026

    Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.

    Papers in Europe PMC
  4. 04
    Saucier N3 papers · 2026

    Division of Rheumatology/Immunology and.

    Papers in Europe PMC
  5. 05
    Schmitz EG3 papers · 2026

    Department of Pediatrics, Division of Rheumatology & Immunology, Washington University School of Medicine in St Louis, St Louis, Mo.

    Papers in Europe PMC
  6. 06
    Bednarski JJ2 papers · 2026

    Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.

    Papers in Europe PMC
  7. 07
    Bleesing JJ2 papers · 2026

    Division of Bone Marrow Transplantation and Immunodeficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Papers in Europe PMC
  8. 08
    Connelly JA2 papers · 2026

    Pediatric Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN.

    Papers in Europe PMC
  9. 09
    De Ravin SS2 papers · 2026

    Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.

    Papers in Europe PMC
  10. 10
    Goldbach-Mansky R2 papers · 2026

    Translational Autoinflammatory Diseases Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

interventional trials for this specific condition

We could not load trial data for this condition right now.

Data as of 11 September 2026 · last trial check 31 July 2026

low confidence

Recruiting interventional trials

From the matched ClinicalTrials.gov set

Trial data could not be loaded for this build. This is not the same as finding zero interventional trials.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for TLR8-related inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("TLR8-related inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome" OR "INFLTR8" OR "Toll-like receptor 8-associated inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome" OR "IMD98" OR "X-linked immunodeficiency with autoinflammation" OR "immunodeficiency 98 with autoinflammation, X-linked" OR "inflammation, neutropenia, bone marrow failure, and lymphoproliferation caused by TLR8") OR ("TLR8" OR "TLR8 syndrome" OR "TLR8-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"TLR8-related inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome"

Query health: suspect — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Source errors: trials: Error: HTTP 400 for https://clinicaltrials.gov/api/v2/studies?query.cond=%22TLR8-related%20inflammation-severe%20neutropenia-bone%20marrow%20failure-lymphoproliferation%20syndrome%22%20OR%20%22INFLTR8%22%20OR%20%22Toll-like%20receptor%208-associated%20inflammation-severe%20neutropenia-bone%20marrow%20failure-lymphoproliferation%20syndrome%22%20OR%20%22IMD98%22%20OR%20%22X-linked%20immunodeficiency%20with%20autoinflammation%22%20OR%20%22immunodeficiency%2098%20with%20autoinflammation%2C%20X-linked%22%20OR%20%22inflammation%2C%20neutropenia%2C%20bone%20marrow%20failure%2C%20and%20lymphoproliferation%20caused%20by%20TLR8%22&format=json&pageSize=100&countTotal=true

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (13820) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity

Ingested 2026-07-27T20:24:15.573Z